Related Experiment Video
Updated: Jul 27, 2026

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
Published on: July 19, 2018
Ultrapure dialysate: a desirable and achievable goal for routine hemodialysis
1Department of Medicine, University of Louisville, Kentucky 40202-1718, USA. richard.ward@louisville.edu
Abstract:
United States standards for the microbiologic quality of dialysate are not very stringent and have remained unchanged for more than 20 years, despite significant changes in the patient population and in the technology of hemodialysis. Numerous studies have demonstrated that bacterial products can cross dialysis membranes and stimulate an inflammatory response in the patient. Inflammation has been implicated in several complications associated with long-term hemodialysis therapy, and the use of ultrapure dialysate has been shown to reduce the incidence of one of these complications, beta2-microglobulin amyloidosis. Since technological innovations in water treatment and improvements in dialysis machine design allow the routine production of ultrapure dialysate, its use should now become standard.
Insights
Current US standards for hemodialysis fluid are outdated. Using ultrapure dialysate can reduce inflammation and complications like beta2-microglobulin amyloidosis, making it a necessary standard of care.
Area of Science:
- Nephrology
- Infectious Disease
- Biomedical Engineering
Background:
- Current US standards for dialysate microbiologic quality are over 20 years old and not stringent.
- Bacterial products in dialysate can cross membranes, causing inflammation in hemodialysis patients.
- Inflammation is linked to complications in long-term hemodialysis.
Purpose of the Study:
- To evaluate the need for updated dialysate quality standards.
- To highlight the benefits of ultrapure dialysate in reducing hemodialysis complications.
Main Methods:
- Review of existing literature on dialysate quality, bacterial translocation, and inflammation.
- Analysis of technological advancements in water treatment and dialysis machine design.
- Assessment of the impact of ultrapure dialysate on patient outcomes, specifically beta2-microglobulin amyloidosis.
Main Results:
- Bacterial products crossing dialysis membranes can trigger inflammatory responses.
- Ultrapure dialysate has demonstrated efficacy in reducing beta2-microglobulin amyloidosis incidence.
- Technological advancements permit routine production of ultrapure dialysate.
Conclusions:
- Outdated dialysate standards pose risks to hemodialysis patients.
- The use of ultrapure dialysate should be adopted as a new standard of care.
- Implementing ultrapure dialysate can mitigate inflammation-related complications in hemodialysis.
Related Concept Videos
Dialysis
Dialysis
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
Peritoneal Dialysis I: Introduction and Procedure
Hemodialysis I: Introduction
Hemodialysis II: Procedure and Complications

